72 related articles for article (PubMed ID: 7924583)
1. Potent deglycosylated ricin A chain immunotoxins specifically killing of xenotropic murine retrovirus-infected cells.
Wu M; Masaaki M; Masato N; Masashisa K
Chin Med J (Engl); 1994 May; 107(5):383-5. PubMed ID: 7924583
[No Abstract] [Full Text] [Related]
2. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.
Till M; May RD; Uhr JW; Thorpe PE; Vitetta ES
Cancer Res; 1988 Mar; 48(5):1119-23. PubMed ID: 3257712
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.
Till MA; Zolla-Pazner S; Gorny MK; Patton JS; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1987-91. PubMed ID: 2538826
[TBL] [Abstract][Full Text] [Related]
4. Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model.
Gottstein C; Schön G; Tawadros S; Kube D; Wargalla-Plate UC; Hansmann ML; Wacker HH; Berthold F; Diehl V; Engert A
Cancer Res; 1994 Dec; 54(23):6186-93. PubMed ID: 7954465
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
6. [Possible use of anti-envelope immunotoxins against HIV-infection].
Matsushita S; Koito A; Maeda Y; Hattori T; Takatsuki K
Nihon Rinsho; 1989 Jan; 47(1):220-6. PubMed ID: 2786096
[No Abstract] [Full Text] [Related]
7. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
Shen GL; Li JL; Vitetta ES
J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
[TBL] [Abstract][Full Text] [Related]
8. The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage.
Baluna R; Coleman E; Jones C; Ghetie V; Vitetta ES
Exp Cell Res; 2000 Aug; 258(2):417-24. PubMed ID: 10896793
[TBL] [Abstract][Full Text] [Related]
9. The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half-life.
Pop LM; Liu X; Ghetie V; Vitetta ES
Int Immunopharmacol; 2005 Jul; 5(7-8):1279-90. PubMed ID: 15914332
[TBL] [Abstract][Full Text] [Related]
10. The in vivo anti-tumor activity of immunotoxins containing two versus one deglycosylated ricin A chains.
Ghetie V; Engert A; Schnell R; Vitetta ES
Cancer Lett; 1995 Nov; 98(1):97-101. PubMed ID: 8529213
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
[TBL] [Abstract][Full Text] [Related]
12. Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome.
Soler-Rodríguez AM; Ghetie MA; Oppenheimer-Marks N; Uhr JW; Vitetta ES
Exp Cell Res; 1993 Jun; 206(2):227-34. PubMed ID: 8388800
[TBL] [Abstract][Full Text] [Related]
13. Role of CD25+ and CD25-T cells in acute HIV infection in vitro.
Ramilo O; Bell KD; Uhr JW; Vitetta ES
J Immunol; 1993 Jun; 150(11):5202-8. PubMed ID: 8496611
[TBL] [Abstract][Full Text] [Related]
14. Association between nuclear antigens and endogenous retrovirus in the generation of autoantibody responses in murine lupus.
Tucker RM; Roark CL; Santiago-Raber ML; Izui S; Kotzin BL
Arthritis Rheum; 2004 Nov; 50(11):3626-36. PubMed ID: 15529369
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of tissue immunogenicity by immunotoxin treatment of human fetal pancreas.
Hullett DA; Landry AS; Leonard DK; Sollinger HW
Transplantation; 1988 Nov; 46(5):771-3. PubMed ID: 2973671
[No Abstract] [Full Text] [Related]
16. Preparation of cytotoxic antibody-toxin conjugates.
Cumber AJ; Wawrzynczak EJ
Methods Mol Biol; 1998; 80():135-44. PubMed ID: 9664370
[No Abstract] [Full Text] [Related]
17. Mouse multivalent IgG(2a, b) antibody--ricin A-chain immunotoxins combined with homologous or heterologous interleukin 2 in the treatment of a murine malignant lymphoproliferation (EL4).
Mota G; Marches R; Cialacu V; Roman V; Kozma E; Mărgineanu M; Dima S; Moraru II
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):131-6. PubMed ID: 8915518
[TBL] [Abstract][Full Text] [Related]
18. Expression of ricin A chain and ricin A chain-KDEL in Escherichia coli.
Zhan J; Chen Y; Wang K; Zheng S
Protein Expr Purif; 2004 Apr; 34(2):197-201. PubMed ID: 15003251
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of ricin-mAb 35 on extraocular muscles of rabbits: potential treatment for strabismus.
Christiansen SP; Peterson D; To T; Youle R; McLoon L
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):679-85. PubMed ID: 11867584
[TBL] [Abstract][Full Text] [Related]
20. Acute effect of bupivacaine and ricin mAb 35 on extraocular muscle in the rabbit.
Park CY; Park SE; Oh SY
Curr Eye Res; 2004; 29(4-5):293-301. PubMed ID: 15590475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
